Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 4/20 | 0.39 |
| ▸ | MGLL | Q99685 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 3/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.37 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.37 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.37 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.37 |
| ▸ | LPL | P06858 | 1/20 | 0.37 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.36 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29547429 | 1.00 | ENPP2 (0.39) | ENPP2MGLLCA2CA1TSHR | |
| Hydrochloric Acid SCHEMBL18889249 | 0.98 | ENPP2 (0.37) | ENPP2MGLLCA2CA1TSHR | |
| SCHEMBL7931541 | 0.82 | CYP2A6 (0.38) | ORAI1ORAI2ORAI3TRPV6CYP2A6 | |
| SCHEMBL1668650 | 0.81 | NAPRT (0.34) | CYP2A6CYP2B6CYP3A4CYP2C19 | |
| SCHEMBL24444783 | 0.77 | CYP2A6 (0.32) | ORAI1ORAI2ORAI3TRPV6CYP2A6 | |
| SCHEMBL25686350 | 0.77 | CYP2A6 (0.35) | ENPP2CA2CA1ORAI1ORAI2 | |
| SCHEMBL24092776 | 0.76 | CYP2A6 (0.36) | CYP2A6CYP2B6CYP3A4CYP2C19CYP2E1 | |
| SCHEMBL38656446 | 0.75 | ENPP2 (0.42) | ENPP2MGLLCA2CA1TSHR | |
| SCHEMBL26314552 | 0.75 | ENPP2 (0.42) | ENPP2MGLLCA2CA1TSHR | |
| SCHEMBL519749 | 0.73 | ENPP2 (0.46) | ENPP2MGLLCA2CA1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2565 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| CN-118307565-A | FHND507 and 507 synthesis method | 南京师范大学 | 2024-07-09 | — | — | CN | claimed |
| CN-115160300-B | Coumarin compound, preparation method thereof and application of coumarin compound in resisting Alzheimer disease | 中国人民解放军北部战区总医院 | 2024-05-31 | — | — | CN | claimed |
| US-20230380457-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-30 | — | — | US | claimed |
| EP-4280882-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2023-11-29 | — | — | EP | claimed |
| US-20230363426-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-16 | — | — | US | claimed |
| US-11793220-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2023-10-24 | — | — | US | claimed |
| CN-116916755-A | Materials and methods for extending the shelf life of food products | JP实验室公司 | 2023-10-20 | — | — | CN | claimed |
| US-11737481-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2023-08-29 | — | — | US | claimed |
| CN-113321668-A | Synthesis of serpatatinib | 江苏慧聚药业有限公司 | 2021-08-31 | — | — | CN | claimed |
| CN-112687878-A | Electrochemical device and electronic device | 东莞新能源科技有限公司 | 2021-04-20 | — | — | CN | claimed |
| EP-2155681-B1 | PROCESS FOR THE PREPARATION OF COMPOSITIONS FOR MODULATING A KINASE CASCADE AND METHODS OF USE THEREOF | ATHENEX INC (US) | 2018-05-02 | — | — | EP | claimed |
| EP-2114934-B1 | COMPOSITION AND METHODS FOR MODULATING A KINASE CASCADE | KINEX PHARMACEUTICALS LLC (US) | 2015-10-21 | — | — | EP | claimed |
| EP-2485678-A1 | COFERONS AND METHODS OF MAKING AND USING THEM | Cornell University (US) | 2012-08-15 | — | — | EP | claimed |
| US-7939529-B2 | Substantially pure 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide salts, solvates, hydrates, prodrugs; hyperproliferative disorders, cancers, pre-cancers, osteoporosis, cardiovascular disorders; bacterial, fungal, parasitic or viral infection | KINEX PHARMACEUTICALS, LLC (US) | 2011-05-10 | — | — | US | claimed |
| WO-2011043817-A1 | COFERONS AND METHODS OF MAKING AND USING THEM | CORNELL UNIVERSITY (US) | 2011-04-14 | — | — | WO | claimed |
| EP-2155681-A1 | PROCESS FOR THE PREPARATION OF COMPOSITIONS FOR MODULATING A KINASE CASCADE AND METHODS OF USE THEREOF | Kinex Pharmaceuticals, LLC (US) | 2010-02-24 | — | — | EP | claimed |
| WO-2008144045-A1 | PROCESS FOR THE PREPARATION OF COMPOSITIONS FOR MODULATING A KINASE CASCADE AND METHODS OF USE THEREOF | KINEX PHARMACEUTICALS, LLC (US) | 2008-11-27 | — | — | WO | claimed |
| US-20080287436-A1 | Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof | SAGARD HEALTHCARE ROYALTY PARTNERS, LP, AS ADMINISTRATIVE AGENT (CA) | 2008-11-20 | — | — | US | claimed |